Understanding Peptide Pharmacokinetics & Half-Life
Pharmacokinetics (PK) is the branch of pharmacology dedicated to determining the fate of substances administered to a living organism. When researching lyophilized peptides, understanding the compound's specific half-life is the absolute foundation of designing an effective dosing protocol.
What is a Half-Life?
A biological half-life is the time required for the concentration of a given compound in the bloodstream to decrease by exactly half. For example, if a researcher administers 1,000mcg of a peptide with a 24-hour half-life, approximately 500mcg will remain active in the system after one day, 250mcg after two days, and so forth.
The Importance of Steady State
When you dose a compound faster than it can completely clear the body, it begins to accumulate. This buildup eventually levels off at what is known as Steady State. The golden rule of pharmacokinetics dictates that steady state is generally achieved after 5 half-lives.
- The Peak: The highest concentration of the compound in the bloodstream, typically occurring shortly after administration.
- The Trough: The lowest concentration of the compound just before the next scheduled dose. Maintaining an optimal trough ensures the compound continues exerting physiological effects 24/7.
Why Model Your Protocol?
Using this calculator prevents catastrophic errors in cycle design. Administering a compound with a 24-hour half-life (like IGF-1 LR3) once a week will result in massive spikes and deep crashes. Conversely, dosing a long-acting compound (like Semaglutide, 168-hour half-life) every day will cause exponential accumulation, leading to severe side effects and rapid receptor downregulation.